Personalizing your Cancer Journey
Qualisure Diagnostics Inc. develops molecular tests that enhance cancer care by identifying features that help oncologists personalize treatment.
Understanding which cancers are indolent or aggressive, and which ones are more likely to respond to certain treatments can guide treatment strategy.
Through innovation and collaboration, we help clinicians decide on the right treatment to provide personalized cancer care to every patient.
Introducing Thyroid GuidePx®
Helping guide your papillary thyroid cancer treatment journey!
Read the research!
Read the research behind our Thyroid GuidePx(R) test! A Clinically Useful and Biologically Informative Genomic…
From doctor to entrepreneur – Oliver Bathe from Qualisure Diagnostics
Listen to our CEO, Dr. Oliver Bathe talk about Qualisure's innovation and the work he's…
2022 American Thyroid Association – Dr. Oliver Bathe
October 19-23 2022. Dr. Oliver Bathe presented results from a study of 742 patients at…